期刊文献+

胰腺癌肝转移免疫治疗的研究进展 被引量:7

Research advances in immunotherapy for liver metastasis of pancreatic cancer
在线阅读 下载PDF
导出
摘要 胰腺癌肝转移的预后极差,手术切除机会少,传统放化疗对其疗效也不理想。免疫治疗作为新的肿瘤治疗策略,能够通过增强患者免疫功能以对抗肿瘤,有望成为胰腺癌肝转移的有效治疗方案。针对免疫调节剂、单克隆抗体、免疫检查点抑制剂、过继细胞免疫和肿瘤疫苗方面,总结了近年来免疫疗法在胰腺癌肝转移治疗中的研究进展,认为联合治疗方案具有积极的应用前景。 Patients with liver metastasis of pancreatic cancer have poor prognosis and few opportunities for surgery,and conventional radiochemotherapy lacks a satisfactory effect. As a new therapeutic strategy for tumor,immunotherapy fights against cancer by enhancing patients′immune function and may thus become an effective treatment regimen for liver metastasis of pancreatic cancer. This article reviews the latestresearch advances in immunotherapy for liver metastasis of pancreatic cancer from the aspects of immunomodulator,monoclonal antibody,immune checkpoint inhibitor,adoptive cellular immunotherapy,and tumor vaccine and points out that a combined treatment regimen has apromising future in clinical application.
作者 金添强 徐锋 戴朝六 JIN Tianqiang;XU Feng;DAI Chaoliu(Department of Hepatobiliary and Splenic Surgery,Shengjing Hospital of China Medical University,Shenyang 110004,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2018年第11期2469-2474,共6页 Journal of Clinical Hepatology
基金 沈阳市科学技术计划项目(17-230-9-16)
关键词 胰腺肿瘤 肝肿瘤 肿瘤转移 免疫疗法 综述 pancreatic neoplasms liver neoplasms neoplasm metastasis immunotherapy review
  • 相关文献

参考文献6

二级参考文献242

  • 1Xu Liu,Xiao-Zhong Guo,Wei-Wei Zhang,Zhuo-Zhuang Lu,Qun-Wei Zhang, Hai-Feng Duan and Li-Sheng Wang State Key Laboratory of Cancer Biology and Institute of Digestive Diseases,Xijing Hospital of Digestive Disease,Fourth Military Medical University,Xi’an 710032,China,Department of Gastroenterology,Shenyang General Hospital of PLA,Shenyang 110016, China,Department of Experimental Hematology,Beijing Institute of Radiation Medicine,Beijing 100850,China.KAI1 inhibits HGF-induced invasion of pancreatic cancer by sphingosine kinase activity[J].Hepatobiliary & Pancreatic Diseases International,2011,10(2):201-208. 被引量:10
  • 2Min-Pei Liu Xiao-Zhong Guo Jian-Hua Xu Di Wang Hong-Yu Li Zhong-Min Cui Jia-Jun Zhao Li-Nan Ren.New tumor-associated antigen SC6 in pancreatic cancer[J].World Journal of Gastroenterology,2005,11(48):7671-7675. 被引量:1
  • 3Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreaticcancer: a report of treatment and survival trends for 100,313patients diagnosed from 1985-1995, using the National CancerDatabase. J Am Coll Surg 1999; 189: 1-7 [PMID: 10401733].
  • 4Gralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, Bonner J, Demetri GD, Curran W, Ganz PA, Kramer BS, KrisMG, Markman M, Mayer RJ, Raghavan D, Ramsey S, ReamanGH, Sawaya R, Schuchter LM, Sweetenham JW, Vahdat LT,Davidson NE, Schilsky RL, Lichter AS. Clinical cancer advances2007: major research advances in cancer treatment, prevention,and screening--a report from the American Society of ClinicalOncology. J Clin Oncol 2008; 26: 313-325 [PMID: 18086794DOI: 10.1200/JCO.2007.15.4088].
  • 5Cancer Facts & Figures 2015. Atlanta: American Cancer Society,2015: 1-56.
  • 6Stathis A, Moore MJ. Advanced pancreatic carcinoma: currenttreatment and future challenges. Nat Rev Clin Oncol 2010; 7:163-172 [PMID: 20101258 DOI: 10.1038/nrclinonc.2009.236].
  • 7Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW,Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, ChakA, Fockens P, Goggins M, Bruno M. International Cancer ofthe Pancreas Screening (CAPS) Consortium summit on themanagement of patients with increased risk for familial pancreaticcancer. Gut 2013; 62: 339-347 [PMID: 23135763 DOI: 10.1136/gutjnl-2012-303108].
  • 8Shi C, Hruban RH, Klein AP. Familial pancreatic cancer. ArchPathol Lab Med 2009; 133: 365-374 [PMID: 19260742 DOI: 10.1043/1543-2165-133.3.365].
  • 9Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, DepinhoRA. Genetics and biology of pancreatic ductal adenocarcinoma.Genes Dev 2006; 20: 1218-1249 [PMID: 16702400 DOI: 10.1101/gad.1415606].
  • 10Ottenhof NA, Milne AN, Morsink FH, Drillenburg P, Ten Kate FJ,Maitra A, Offerhaus GJ. Pancreatic intraepithelial neoplasia andpancreatic tumorigenesis: of mice and men. Arch Pathol Lab Med2009; 133: 375-381 [PMID: 19260743 DOI: 10.1043/1543-2165-133.3.375].

共引文献57

同被引文献44

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部